可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Wainstein M, Frederic F, Lee M, et al. Lack of clinical efficacy of pharmacologic treatment of the noflow phenomenon despite significant angiographic improvement[J]. J Am Coll Cardiol, 2001, 37(2): 83A.
[2]Sakuma T, LeongPoi H, Fisher NG, et al. Further insights into the noreflow phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli[J]. J Am Soc Echocardiogr, 2003, 16:15-21.
[3]David A, Renato V, Angela M, et al. Direct infarct artery stenting without predilation and noreflow in patients with acute myocardial infarction[J]. Am Heart J, 2001, 142: 684-690.
[4]Sabatier R, Hamon M, Zhao QM, et al. Could direct stenting reduce noreflow in acute coronary syndromes? A randomized pilot study[J]. Am Heart J, 2002, 143: 1027-1032.
[5] Atmaca Y, Altin T. Ozdol SC, et al. Direct stent implantation in acute coronary syndrome[J]. J Invasive Cardiol, 2002, 14: 308-312.
[6]Resnie FS, Wainstein M, Lee MK, et al. Noreflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention[J]. Am Heart J, 2003, 145: 42-46.